2006
DOI: 10.1016/j.ejphar.2006.08.036
|View full text |Cite
|
Sign up to set email alerts
|

The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
25
1

Year Published

2007
2007
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(32 citation statements)
references
References 35 publications
6
25
1
Order By: Relevance
“…37 Indeed, isome-proliferator activated receptors ␣ and ␥ agonists were shown recently to suppress vascular ACE expression in stretozotocin-induced diabetic rats. 38 …”
Section: Ace and Renin Mrna Expression In Renal And Adipose Tissues Omentioning
confidence: 99%
“…37 Indeed, isome-proliferator activated receptors ␣ and ␥ agonists were shown recently to suppress vascular ACE expression in stretozotocin-induced diabetic rats. 38 …”
Section: Ace and Renin Mrna Expression In Renal And Adipose Tissues Omentioning
confidence: 99%
“…One study has shown that a PPARγ ligand inhibits expression of the NADPH oxidase subunits p22 phox and p47 phox in vitro (19). Another study has shown that PPARγ ligands inhibit NADPH oxidase expression in the streptozotocin-induced diabetic rat aorta in vivo (4). Here, p22 phox expression was significantly reduced in the aortae of telmisartan-treated SHR-SP and sodium-loaded SHR-SP compared with placebo-treated rats, whereas valsartan did not attenuate p22 phox expression.…”
Section: Fig 5 Ace Activities In Wky Rats Placebo (P)- Telmisartamentioning
confidence: 62%
“…Toba et al . ( 4 ) reported that PPAR γ ligands, pioglitazone and bezafibrate, prevent the streptozotocin-induced increase in vascular ACE gene expression and protein content in rats. However, it remains unclear whether or not telmisartan has more effective vascular ACE activity than other ARBs that have no PPAR γ agonistic effect.…”
Section: Introductionmentioning
confidence: 99%
“…one study found the ACE activity in blood to be related with the ACE I/D genotype, partially due to an increased rate of transcription of the ACE D allele 29) . Recently, Toba et al reported that pioglitazone exerted anti-oxidative and anti-inflammatory effects through the inhibition of ACE expression in the aorta of rats with streptozotocin-induced diabetes 30) . Together with increased expression of the ACE gene and increased renin-angiotensin system (RAS)-induced oxidative stress, pioglitazone may modulate oxidative stress-induced progression of atherosclerosis by acting on the augmented RAS system in subjects with type 2 diabetes.…”
Section: Discussionmentioning
confidence: 99%